Library / Peptides / Longevity & Anti-Aging / Testagen
No human data · Grade D

Testagen

Testagen (Khavinson Tetrapeptide)
Evidence
No Human Data
Route
Oral or Sublingual
Frequency
Once daily
Category
Longevity & Anti-Aging
TL;DR
Testagen is an obscure Russian peptide claimed to boost testosterone production by 'reminding' testicular cells how to function better as they age. The science behind it comes almost entirely from one research group in Russia and has not been independently confirmed. There is no meaningful human clinical trial data. Men with low testosterone have much better-studied options available through their doctor.
Part 01 · How it works

Mechanism.

Testagen is a synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Gly) developed by Russian researcher Vladimir Khavinson, purported to act on gonadal tissue and support testosterone production and reproductive function in aging males. Like other Khavinson bioregulators, it is theorized to work via epigenetic mechanisms by binding specific gene promoter regions.

Khavinson's theory is that short peptides act like zip codes — each one is addressed to a specific organ and, when delivered, acts like an instruction manual that reminds aging cells how to do their job properly. Testagen is supposedly addressed to the testes.

Mechanism · technical
According to Khavinson's bioregulator peptide theory, short peptides derived from specific tissues home to those tissues and regulate gene expression through chromatin remodeling and transcription factor interactions. Testagen is theorized to bind to DNA regions in testicular Leydig cells, promoting expression of genes involved in steroidogenesis and androgen synthesis. No peer-reviewed mechanistic data in humans exists to validate this claim.
Part 02 · Dosing & administration

How it's taken.

Values below describe how Testagen has been administered in published trials and labeling. Provided for educational purposes only — this is not medical advice and not instructions for self-administration. Consult your healthcare provider before making any health decision.

Standard dose
10-20 mg oral
Oral or Sublingual · Once daily
Duration
10-20 day cycles, repeated every 3-6 months

Khavinson tetrapeptide bioregulator for testicular tissue. Based on Russian bioregulatory peptide protocols. No FDA-approved indication. Very limited clinical data.

Need help with reconstitution?

Use the free peptide calculator for dilution, unit conversion, and injection volume.

Open calculator
Part 03 · Safety

Side effects, rare serious events, who shouldn't.

Reported side effects
No clinical safety data available in peer-reviewed literature. Risks are unknown. Potential for contaminated or mislabeled product from unregulated sources. Theoretical risks include disruption of the hypothalamic-pituitary-gonadal axis.
Absolute · do not use
×
Pregnancy or breastfeeding
×
Children under 18
×
Known hypersensitivity to testagen or any component
×
Hormone-sensitive cancers (theoretical concern with any peptide affecting reproductive axis)
Interactions
Testosterone replacement therapy
Testagen is a bioregulator peptide targeting testicular function; may have additive effects on testosterone levels
Moderate
Aromatase inhibitors
Changes in testosterone production may alter estrogen balance; monitor hormone levels
Minor
GnRH agonists/antagonists
Testagen may interact with hypothalamic-pituitary-gonadal axis signaling
Moderate
Labs to monitor
Total and Free Testosterone
Baseline and at end of cycle
Testagen purportedly supports testicular function
LH and FSH
Baseline and at end of cycle
Monitor gonadotropin levels
CMP (Comprehensive Metabolic Panel)
Baseline and every 3 months
General metabolic safety
CBC with Differential
Baseline and every 3 months
General safety monitoring
Part 04 · Research log

Every study we cite.

Each study with its published finding and a plain-language note on limitations or funding.

01
2003
0
Peptide bioregulators and gonadal function: Khavinson Institute findings
Russian-language publications from the St. Petersburg Institute of Bioregulation describe improvements in Leydig cell function and testosterone levels in aging animal models with Testagen-like tetrapeptides.
Published in Russian-language journals with limited independent replication. Institutional conflict of interest (developer=publisher). No peer-reviewed Western replication.
02
2014
0
Short peptides as epigenetic regulators: Khavinson's bioregulator theory
A review by Khavinson et al. describes the theoretical framework for peptide bioregulators including DNA-binding properties, but lacks mechanistic human data.
Author-produced review, not independently validated. Theory is not widely accepted in mainstream endocrinology or molecular biology.
PMID 24549503 ↗
Part 05 · Cost & access

Where you can get it.

Regulatory status
Not FDA-approved. Not approved by EMA. Sold as a research peptide or supplement in some countries. Regulatory status varies; classified as an unregistered experimental compound in most Western jurisdictions.
The Peptide Column takes no affiliate commission from any source.
Part 06 · Your appointment

Questions to bring.

01
Are there any published peer-reviewed human trials of Testagen that have been independently replicated?
02
What are the risks of attempting to influence testosterone production with an uncharacterized peptide?
03
How does this compare to evidence-based interventions for age-related low testosterone?
04
Is the source and purity of Testagen verifiable if obtained from research chemical suppliers?